Medical specialists from Belgium tagged as investigators in clinical trials studying Leukemia
Total 58 results
-
Jutte Van der Werff Ten Bosch, M.D.Seen in:
- Brussels, University Hospital Brussels
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Ka Lung WUSeen in:
- Antwerpen, Z.N.A. Stuivenberg Ziekenhuis
Trials:- NCT03887156 (Sub-Investigator)
-
Koen Norga, M.D.Seen in:
- Edegem, University Hospital Antwerp
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Laurence Dedeken, M.D.Seen in:
- Brussels, L'hôpital Universitaire des enfants Reine Fabiola (Huderf)
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Lien DeleuSeen in:
- West Flanders, Roeselare, AZ Delta
Trials:- NCT04666038 (Principal Investigator)
- NCT05254743 (Principal Investigator)
-
Liesbet LammertijnSeen in:
- Hasselt, BE-Hasselt-VIRGAJESSE
Trials:- NCT04027309 (Principal Investigator)
-
Maelle Deville, M.D.Seen in:
- Brussels, Cliniques Universitaires Saint-Luc (UCL)
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Marie Françoise DRESSE, MDSeen in:
- Ghent, University Hospital of Ghent
- Liège, Centre Hospitalier Universitaire de Liege Domaine Universitaire du Sart Tilman
Trials:- NCT01281735 (Sub-Investigator)
- NCT01949129 (Principal Investigator)
Conditions: -
Marie-Christiane VekemansSeen in:
- Brussels, BE-Bruxelles-STLUC
- Vlaams Brabant, Woluwe-Saint-Lambert, Cliniques Universitaires Saint-Luc
Trials:- NCT04027309 (Principal Investigator)
- NCT04053933 (Principal Investigator)
-
Marie-Françoise Dresse, M.D.Seen in:
- Liège, CHR de la Citadelle
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Marleen Renard, MD PhDSeen in:
- Leuven, University Hospitals Leuven Kinderhemato-oncologie
Trials:- NCT01949129 (Principal Investigator)
Conditions: -
Marlies BEKAERTSeen in:
- Ghent, University Hospital of Ghent
Trials:- NCT01281735 (Sub-Investigator)
Conditions: -
Nikki GRANACHERSeen in:
- Antwerpen, Z.N.A. Stuivenberg Ziekenhuis
Trials:- NCT03887156 (Sub-Investigator)
-
Pauline Mazilier, MD, PhDSeen in:
- Brussels, L'hôpital Universitaire des enfants Reine Fabiola (Huderf)
Trials:- NCT05477589 (Principal Investigator)
-
Philippe Martiat, MD PhDSeen in:
- Brussels, Institut Jules Bordet, tumor center of the Universite Libre de Bruxelles
Trials:- NCT01513109 (Principal Investigator)
-
Rik Schots, MD PhDSeen in:
- Brussels, UZ Brussel
Trials:- NCT03852407 (Sub-Investigator)
-
Sophie SERVAIS, DrSeen in:
- Liège, CHU Liège
- Liège, CHU de Liège
Trials:- NCT03887156 (Sub-Investigator)
- NCT03852407 (Sub-Investigator)
Conditions:- Acute Lymphoblastic Leukemia;
- Acute Myeloid Leukemia in Remission;
- Lymphoma in Remission;
- Non-progressive Myeloproliferative Syndrome;
- Myelodysplasia With Stable Blasts is Cell Number and < 10% of Blastocysts;
- Acute Leukemia Biphenotypic in Remission;
- Myelodysplastic Syndromes;
- Multiple Myeloma;
- Hodgkin Lymphoma;
- Non Hodgkin Lymphoma;
- Myeloproliferative Disorder;
- Chronic Lymphoid Leukemia;
- Myeloproliferative Syndrome;
- Chronic Myeloid Leukemia in Remission;
- Acute Lymphoid Leukemia in Remission
-
Thierry ConnerotteSeen in:
- Other, Ottignies, Clinique Saint Pierre
- Ottignies, Clinique Saint Pierre Ottignies
- Ottignies-Louvain-la-Neuve, BR Clinic Saint Pierre Ottignies
Trials:- NCT04666038 (Principal Investigator)
- NCT04404283 (Principal Investigator)
- NCT04053933 (Principal Investigator)
-
Tom EYCKMANSSeen in:
- Antwerpen, Z.N.A. Stuivenberg Ziekenhuis
Trials:- NCT03887156 (Sub-Investigator)
-
Vanessa DelrieuSeen in:
- Haine-Saint-Paul, Groupe Jolimont
- Haine-Saint-Paul, Hopital de Jolimont
Trials:- NCT04965493 (Principal Investigator)
- NCT04666038 (Principal Investigator)
Conditions: -
Vanessa Van HendeSeen in:
- East Flanders, Sint-Niklaas, Vzw - Vitaz
- Oost-Vlaanderen, Sint-Niklaas, Vitaz
Trials:- NCT04666038 (Principal Investigator)
- NCT05254743 (Principal Investigator)
- NCT06097364 (Principal Investigator)
-
Veerle Mondelaers, M.D.Seen in:
- Ghent, University Hospital Ghent
Trials:- NCT04307576 (Principal Investigator)
Conditions: -
Victoria Bordon, MD, PhDSeen in:
- Ghent, Department of Pediatric Hematology, Oncology and SCT, Ghent University Hospital
Trials:- NCT05477589 (Principal Investigator)
-
Viktoria Bourdon, MD, PhDSeen in:
- Gent, University Hospital Gent Pediatrische hemato-oncologie
Trials:- NCT01949129 (Principal Investigator)
Conditions: -
YVES BEGUIN, MDSeen in:
- Liège, CHU Liège
Trials:- NCT04167696 (Principal Investigator)
Conditions: -
Zwi N Berneman, MD, PhDSeen in:
- Antwerp, Antwerp University Hospital
Trials:- NCT01686334 (Principal Investigator)
Conditions:
Clinical Trials on Leukemia
-
Stanford UniversityTerminatedLeukemia | Leukemia, Lymphocytic, Acute | Leukemia Acute Promyelocytic Leukemia (APL) | Leukemia Acute Lymphoid Leukemia (ALL) | Leukemia Chronic Myelogenous Leukemia (CML) | Leukemia Acute Myeloid Leukemia (AML) | Leukemia Chronic Lymphocytic Leukemia (CLL)United States
-
Massachusetts General HospitalCelgene CorporationTerminatedAcute Myelogenous Leukemia | Acute Myeloid Leukemia (AML) | Acute Myelocytic Leukemia | Acute Granulocytic Leukemia | Acute Non-Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic Leukemia | Adult Acute Myeloid Leukemia With Maturation | Adult Acute Myeloid Leukemia Without Maturation | Adult Acute Myelomonocytic Leukemia | Alkylating Agent-Related Acute Myeloid... and other conditionsUnited States
-
Hoffmann-La RocheCompletedNeoplasms, Myelogenous Leukemia, AcuteUnited States, Canada
-
Genzyme, a Sanofi CompanyCompletedAcute Myelogenous LeukemiaJapan
-
Institute of Hematology & Blood Diseases HospitalBejing Institute for Stem Cell and Regenerative Medicine; Institute for Stem...RecruitingRefractory Leukemia | Relapsed Leukemia | Acute Myeloid Leukemia, ChildhoodChina
-
Seagen Inc.CompletedAcute Myeloid Leukemia | Acute Myelogenous Leukemia | Acute Promyelocytic LeukemiaUnited States
-
Betta Pharmaceuticals Co., Ltd.Not yet recruitingAcute Myeloid Leukemia LeukemiaChina
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Monoblastic Leukemia (M5a) | Childhood Acute Monocytic Leukemia (M5b) | Childhood Acute Myeloblastic Leukemia Without Maturation (M1) | Childhood Acute Myelomonocytic Leukemia (M4) | Childhood Acute Myeloid Leukemia/Other Myeloid MalignanciesUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted